"Our ambition is to train future diabetes researchers at the Danish Diabetes Academy to use a cross-sectoral and cross-disciplinary approach in their work. The broader purpose is to enable researchers to develop new types of treatment that can prevent the individual and societal consequences of diabetes," said Allan Flyvbjerg, CEO at Steno Diabetes Center Copenhagen, who was recently appointed as the new Chairman of the Board of Directors and the overall manager of the Academy.
The Novo Nordisk Foundation has awarded the Academy a grant of DKK 156 million, and the Danish Diabetes Academy will use this grant to launch a range of training activities, including Ph.D. and postdoctoral courses focusing on talent management and career development of young researchers. Additionally the Academy will offer up to 45 Ph.D. fellowships and up to 40 postdoctoral fellowships as well as a number of international visiting professorships. Furthermore, the academy will hold a number of outreach events, including conferences to strengthen networks and collaboration between researchers at national and international level.
About the Danish Diabetes Academy
The Academy is strategically managed by a diverse Board of Directors. Day-to-day management is carried out by a secretariat based at Odense University Hospital.
The Danish Diabetes Academy is a national initiative for diabetes research and research training which attracts both senior and junior researchers from universities, hospitals and businesses in Denmark. The overall objective of the Academy is to raise the standard of diabetes research education. A specific objective is to provide talented young researchers with the opportunity to improve their qualifications and pursue a career within the field.
The Danish Academy website